To confirm the involvement of IFN in SARS-CoV-2 inhibition by a concurrent pre-existing infection with RV, IAV and IBV, similar sequential assays were then performed but in the presence of neutralizing anti-type I and III IFNs antibodies. The gene discussed is SGCG; the disease is infection.